YCBD
Income statement / Annual
Last year (2025), cbdMD Inc's total revenue was $19.19 M,
a decrease of 1.50% from the previous year.
In 2025, cbdMD Inc's net income was -$2.04 M.
See cbdMD Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
09/30/2025 |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
| Operating Revenue |
$19.19 M |
$19.48 M |
$24.16 M |
$35.40 M |
$44.48 M |
$41.88 M |
$23.65 M |
$459.09 K |
$4.47 M |
$2.03 M |
| Cost of Revenue |
$8.35 M
|
$8.64 M
|
$11.12 M
|
$14.90 M
|
$15.51 M
|
$15.51 M
|
$9.14 M
|
$326.56 K
|
$1.36 M
|
$1.62 M
|
| Gross Profit |
$10.84 M
|
$10.85 M
|
$13.04 M
|
$20.50 M
|
$28.97 M
|
$26.37 M
|
$14.51 M
|
$132.54 K
|
$3.12 M
|
$413.13 K
|
| Gross Profit Ratio |
0.56
|
0.56
|
0.54
|
0.58
|
0.65
|
0.63
|
0.61
|
0.29
|
0.7
|
0.2
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.00 M
|
$14.04 M
|
$22.31 M
|
$37.81 M
|
$48.58 M
|
$43.95 M
|
$28.88 M
|
$1.93 M
|
$3.36 M
|
$4.15 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$13.00 M
|
$14.04 M
|
$22.31 M
|
$37.81 M
|
$48.58 M
|
$43.95 M
|
$28.88 M
|
$1.93 M
|
$3.36 M
|
$4.15 M
|
| Cost And Expenses |
$21.35 M
|
$22.67 M
|
$33.42 M
|
$52.71 M
|
$64.10 M
|
$59.47 M
|
$38.01 M
|
$2.26 M
|
$4.71 M
|
$5.76 M
|
| Interest Income |
$34.31 K
|
$0.00
|
$63.70 K
|
$16.25 K
|
$0.00
|
$39.88 K
|
$75.07 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$29.51 K
|
$0.00
|
$0.00
|
$28.93 K
|
$0.00
|
$0.00
|
$955.00
|
$500.63 K
|
$154.98 K
|
| Depreciation & Amortization |
$1.80 M
|
$1.82 M
|
$2.93 M
|
$2.97 M
|
$2.25 M
|
$1.90 M
|
$289.57 K
|
$222.55 K
|
$71.28 K
|
$44.94 K
|
| EBITDA |
-$366.67 K |
-$1.37 M |
-$6.34 M |
-$14.34 M |
-$17.36 M |
-$15.68 M |
-$14.07 M |
-$1.57 M |
-$168.02 K |
-$3.69 M |
| EBITDA Ratio |
-0.02
|
-0.07
|
-0.26
|
-0.41
|
-0.39
|
-0.37
|
-0.59
|
-3.43
|
-0.04
|
-1.82
|
| Operating Income Ratio |
-0.11
|
-0.16
|
-0.38
|
-0.49
|
-0.44
|
-0.42
|
-0.61
|
-3.91
|
-0.05
|
-1.84
|
| Total Other Income/Expenses Net |
$121.69 K
|
-$510.55 K
|
-$13.67 M
|
-$52.77 M
|
-$4.67 M
|
$28.89 M
|
-$33.43 M
|
$0.00
|
-$1.12 M
|
-$154.98 K
|
| Income Before Tax |
-$2.04 M
|
-$3.70 M
|
-$22.94 M
|
-$70.08 M
|
-$24.29 M
|
$11.31 M
|
-$47.79 M
|
-$1.80 M
|
-$1.36 M
|
-$3.89 M
|
| Income Before Tax Ratio |
-0.11
|
-0.19
|
-0.95
|
-1.98
|
-0.55
|
0.27
|
-2.02
|
-3.91
|
-0.3
|
-1.91
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$895.00 K
|
-$1.35 M
|
-$2.36 M
|
$0.00
|
$25.00 K
|
$8.00 K
|
| Net Income |
-$2.04 M
|
-$3.70 M
|
-$22.94 M
|
-$70.08 M
|
-$23.39 M
|
$12.60 M
|
-$50.43 M
|
-$412.08 K
|
-$1.74 M
|
-$3.36 M
|
| Net Income Ratio |
-0.11
|
-0.19
|
-0.95
|
-1.98
|
-0.53
|
0.3
|
-2.13
|
-0.9
|
-0.39
|
-1.65
|
| EPS |
-1.09 |
-1.79 |
-13.32 |
-55.8 |
-19.16 |
12.47 |
-114.29 |
-2.39 |
-10.44 |
-36.58 |
| EPS Diluted |
-1.09 |
-1.79 |
-13.32 |
-55.8 |
-19.16 |
12.19 |
-114.29 |
-2.39 |
-10.44 |
-36.58 |
| Weighted Average Shares Out |
$4.02 M
|
$4.31 M
|
$2.02 M
|
$1.33 M
|
$1.22 M
|
$980.90 K
|
$397.49 K
|
$172.06 K
|
$166.49 K
|
$91.75 K
|
| Weighted Average Shares Out Diluted |
$4.02 M
|
$4.31 M
|
$2.02 M
|
$1.33 M
|
$1.22 M
|
$1.00 M
|
$397.49 K
|
$172.22 K
|
$166.49 K
|
$91.75 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
